Mai M. Abouzeid, Mohamed Ghonim, Hamid Boulares. "Turning clinically approved PARP inhibitors into immunotherapy sensitizers by reprogramming the tumor microenvironment in colorectal cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e14552